WallStreetZenWallStreetZen

NASDAQ: AMED
Amedisys Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

AMED past earnings growth

How has AMED's earnings growth performed historically?
Company
-43.06%
Industry
-11.16%
Market
30.64%
AMED's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
AMED's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
AMED's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

AMED past revenue growth

How has AMED's revenue growth performed historically?
Company
0.41%
Industry
11.17%
Market
17.32%
AMED's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AMED's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AMED's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AMED earnings and revenue history

Current Revenue
$2.2B
Current Earnings
$118.6M
Current Profit Margin
5.3%

AMED Return on Equity

Current Company
11.8%
Current Industry
-63.9%
Current Market
184.9%
AMED's Return on Equity (11.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AMED announces earnings.

AMED Return on Assets

Current Company
6%
Current Industry
5.8%
AMED is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AMED Return on Capital Employed

Current Company
11.31%
Current Industry
11.8%
AMED's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AMED vs Medical Care Facility Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AMED$2.22B$254.35M$118.61M+8.03%+32.32%
AMEH$1.14B$110.60M$49.05M+26.28%+1.54%
LFST$859.54M-$105.44M-$215.56M+144.94%N/A
ADUS$951.12M$83.14M$46.03M+17.43%+22.76%
SEM$6.33B$596.48M$158.99M+7.73%-1.55%
View Top Medical Care Facility Stocks

AMED earnings dates

Next earnings date
Apr 25, 2023

Amedisys Earnings & Revenue FAQ

What were AMED's earnings last quarter?

On Invalid Date, Amedisys (NASDAQ: AMED) reported Q4 2022 earnings per share (EPS) of $0.98, up 6.67% year over year. Total Amedisys earnings for the quarter were $31.72 million. In the same quarter last year, Amedisys's earnings per share (EPS) was $1.05.

If you're new to stock investing, here's how to buy Amedisys stock.

What was AMED's earnings growth in the past year?

As of Q1 2023, Amedisys's earnings has grown -43.06% year over year. This is 31.9 percentage points lower than the US Medical Care Facilities industry earnings growth rate of -11.16%. Amedisys's earnings in the past year totalled $118.61 million.

What is AMED's earnings date?

Amedisys's earnings date is Invalid Date. Add AMED to your watchlist to be reminded of AMED's next earnings announcement.

What was AMED's revenue last quarter?

On Invalid Date, Amedisys (NASDAQ: AMED) reported Q4 2022 revenue of $562.06 million up 0.49% year over year. In the same quarter last year, Amedisys's revenue was $559.32 million.

What was AMED's revenue growth in the past year?

As of Q1 2023, Amedisys's revenue has grown 0.41% year over year. This is 10.76 percentage points lower than the US Medical Care Facilities industry revenue growth rate of 11.17%. Amedisys's revenue in the past year totalled $2.22 billion.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.